Literature DB >> 32496023

Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH.

Tobias Tritschler1,2, Noémie Kraaijpoel3, Philippe Girard4,5, Harry R Büller3, Nicole Langlois1, Marc Righini6, Sam Schulman7,8, Annelise Segers9, Grégoire Le Gal1.   

Abstract

Pulmonary embolism (PE)-related death is often a component of the primary outcome in venous thromboembolism (VTE) clinical studies. Definitions for PE-related death vary widely, which may lead to biased risk estimates of clinical outcomes, thereby affecting both internal and external validity of study results. We here provide a standardized definition of PE-related death and propose guidance for classification and reporting of the cause of death for clinical studies in VTE. The proposal was developed in a four-step process, including a systematic review of definitions used for PE-related death in previous studies, two subsequent surveys with VTE experts, and meetings held within the Scientific and Standardization Committee (SSC) working group until consensus on the proposal was reached. The proposed classification comprises three categories: Category A: PE-related death, category B: undetermined cause of death, and category C: cause of death other than PE. Category A includes A1: autopsy-confirmed PE in the absence of another more likely cause of death; A2: objectively confirmed PE before death in the absence of another more likely cause of death; and A3: PE is not objectively confirmed, but is most likely the main cause of death. Category B includes B1: cause of death is undetermined, despite available information; and B2: insufficient clinical information available to determine the cause of death. The use of the proposed definition will hopefully improve the accuracy of study outcomes, between-study comparisons, meta-analyses, and validity of future clinical VTE studies.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  cause of death; classification; mortality; pulmonary embolism; venous thromboembolism

Mesh:

Year:  2020        PMID: 32496023     DOI: 10.1111/jth.14769

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  8 in total

1.  A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies.

Authors:  Deborah M Siegal; Geoffrey D Barnes; Nicole J Langlois; Adrienne Lee; Saskia Middeldorp; Leslie Skeith; William A Wood; Grégoire Le Gal
Journal:  Blood Adv       Date:  2020-12-22

2.  Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team.

Authors:  Romain Chopard; Umberto Campia; Lucas Morin; Karola S Jering; Zaid I Almarzooq; Julia Elizabeth Snyder; Samantha Rizzo; Aaron B Waxman; Samuel Z Goldhaber; Gregory Piazza
Journal:  J Thromb Thrombolysis       Date:  2022-09-03       Impact factor: 5.221

3.  Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study.

Authors:  Damien Choffat; Pauline Darbellay Farhoumand; Evrim Jaccard; Roxane de la Harpe; Vanessa Kraege; Malik Benmachiche; Christel Gerber; Salomé Leuzinger; Clara Podmore; Minh Khoa Truong; Céline Dumans-Louis; Christophe Marti; Jean-Luc Reny; Drahomir Aujesky; Damiana Rakovic; Andreas Limacher; Jean-Benoît Rossel; Christine Baumgartner; Marie Méan
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

4.  Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial.

Authors:  Yonathan Freund; Anthony Chauvin; Sonia Jimenez; Anne-Laure Philippon; Sonja Curac; Florent Fémy; Judith Gorlicki; Tahar Chouihed; Hélène Goulet; Emmanuel Montassier; Margaux Dumont; Laura Lozano Polo; Pierrick Le Borgne; Mehdi Khellaf; Donia Bouzid; Pierre-Alexis Raynal; Nizar Abdessaied; Saïd Laribi; Jeremy Guenezan; Olivier Ganansia; Ben Bloom; Oscar Miró; Marine Cachanado; Tabassome Simon
Journal:  JAMA       Date:  2021-12-07       Impact factor: 157.335

5.  Background of fatal pulmonary embolism: an analysis of all diagnosed fatal pulmonary embolism in 2015-2018 from Hospital District of Helsinki and Uusimaa.

Authors:  Sane Markus Antero
Journal:  J Thromb Thrombolysis       Date:  2021-08-16       Impact factor: 2.300

Review 6.  Pulmonary Embolism in the Cancer Associated Thrombosis Landscape.

Authors:  Géraldine Poenou; Teona Dumitru Dumitru; Ludovic Lafaie; Valentine Mismetti; Elie Ayoub; Cécile Duvillard; Sandrine Accassat; Patrick Mismetti; Marco Heestermans; Laurent Bertoletti
Journal:  J Clin Med       Date:  2022-09-25       Impact factor: 4.964

7.  Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database.

Authors:  Stefano Barco; Luca Valerio; Walter Ageno; Alexander T Cohen; Samuel Z Goldhaber; Beverley J Hunt; Alfonso Iorio; David Jimenez; Frederikus A Klok; Nils Kucher; Seyed Hamidreza Mahmoudpour; Saskia Middeldorp; Thomas Münzel; Vicky Tagalakis; Aaron M Wendelboe; Stavros V Konstantinides
Journal:  Lancet Respir Med       Date:  2020-10-12       Impact factor: 30.700

8.  Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries.

Authors:  Stefano Barco; Luca Valerio; Andrea Gallo; Giacomo Turatti; Seyed Hamidreza Mahmoudpour; Walter Ageno; Lana A Castellucci; Gabriela Cesarman-Maus; Henry Ddungu; Erich Vinicius De Paula; Mert Dumantepe; Samuel Z Goldhaber; Maria Cecilia Guillermo Esposito; Frederikus A Klok; Nils Kucher; Claire McLintock; Fionnuala Ní Áinle; Paolo Simioni; David Spirk; Alex C Spyropoulos; Tetsumei Urano; Zhen-Guo Zhai; Beverley J Hunt; Stavros V Konstantinides
Journal:  Res Pract Thromb Haemost       Date:  2021-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.